{"id":"https://openalex.org/W2990670839","doi":"https://doi.org/10.1634/theoncologist.2019-0518","title":"The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma","display_name":"The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma","publication_year":2019,"publication_date":"2019-11-29","ids":{"openalex":"https://openalex.org/W2990670839","doi":"https://doi.org/10.1634/theoncologist.2019-0518","mag":"2990670839","pmid":"https://pubmed.ncbi.nlm.nih.gov/32162820","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7066699"},"language":"en","primary_location":{"id":"doi:10.1634/theoncologist.2019-0518","doi":"https://doi.org/10.1634/theoncologist.2019-0518","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2019-0518","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2019-0518","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089223773","display_name":"Daniel Y. Wang","orcid":"https://orcid.org/0000-0002-3341-8652","observed_orcids":["https://orcid.org/0000-0002-3341-8652"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Y. Wang","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077265672","display_name":"Jennifer Leigh McQuade","orcid":"https://orcid.org/0000-0002-2393-2172","observed_orcids":["https://orcid.org/0000-0002-2393-2172"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer L. McQuade","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rajat R. Rai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rajat R. Rai","raw_affiliation_strings":["Melanoma Institute Australia, Sydney, Australia","The University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, Australia","institution_ids":["https://openalex.org/I4210118383"]},{"raw_affiliation_string":"The University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034431014","display_name":"John Park","orcid":"https://orcid.org/0000-0001-9290-8179","observed_orcids":["https://orcid.org/0000-0001-9290-8179"]},"institutions":[{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John J. Park","raw_affiliation_strings":["Royal North Shore and Mater Hospitals, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal North Shore and Mater Hospitals, Sydney, Australia","institution_ids":["https://openalex.org/I2800079252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084130453","display_name":"Shilin Zhao","orcid":"https://orcid.org/0000-0002-3921-3965","observed_orcids":["https://orcid.org/0000-0002-3921-3965"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shilin Zhao","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100357202","display_name":"Fei Ye","orcid":"https://orcid.org/0000-0001-6472-5076","observed_orcids":["https://orcid.org/0000-0001-6472-5076"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fei Ye","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074077037","display_name":"Kathryn Eby Beckermann","orcid":"https://orcid.org/0000-0002-4616-6140","observed_orcids":["https://orcid.org/0000-0002-4616-6140"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn E. Beckermann","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079808194","display_name":"Samuel M. Rubinstein","orcid":"https://orcid.org/0000-0002-5568-4441","observed_orcids":["https://orcid.org/0000-0002-5568-4441"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel M. Rubinstein","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032059539","display_name":"Romany Anne Nilanthi Johnpulle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Romany Johnpulle","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina V. Long","raw_affiliation_strings":["Melanoma Institute Australia, Sydney, Australia","Royal North Shore and Mater Hospitals, Sydney, Australia","The University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, Australia","institution_ids":["https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Royal North Shore and Mater Hospitals, Sydney, Australia","institution_ids":["https://openalex.org/I2800079252"]},{"raw_affiliation_string":"The University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Matteo S. Carlino","raw_affiliation_strings":["Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia","Melanoma Institute Australia, Sydney, Australia","The University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I2803024705"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, Australia","institution_ids":["https://openalex.org/I4210118383"]},{"raw_affiliation_string":"The University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520811","display_name":"Alexander Maxwell Menzies","orcid":"https://orcid.org/0000-0001-5183-7562","observed_orcids":["https://orcid.org/0000-0001-5183-7562"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alexander M. Menzies","raw_affiliation_strings":["Melanoma Institute Australia, Sydney, Australia","Royal North Shore and Mater Hospitals, Sydney, Australia","The University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, Australia","institution_ids":["https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Royal North Shore and Mater Hospitals, Sydney, Australia","institution_ids":["https://openalex.org/I2800079252"]},{"raw_affiliation_string":"The University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Douglas B. Johnson","raw_affiliation_strings":["Vanderbilt University, Nashville, Tennesee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, Tennesee, USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5025067315","https://openalex.org/A5089223773"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":1450,"currency":"USD","value_usd":1450},"apc_paid":null,"fwci":3.1267,"has_fulltext":true,"cited_by_count":54,"citation_normalized_percentile":{"value":0.93577503,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"25","issue":"3","first_page":"e602","last_page":"e605"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9229999780654907},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8880000114440918},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.8769999742507935},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.47699999809265137},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7179999947547913},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9634765386581421},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6621044278144836},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.6556594967842102},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6544807553291321},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5661850571632385},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.5109754800796509},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.454105943441391},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4256497621536255},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40014946460723877},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1634/theoncologist.2019-0518","doi":"https://doi.org/10.1634/theoncologist.2019-0518","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2019-0518","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6074933","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7066699","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7066699","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7066699","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:32162820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32162820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1634/theoncologist.2019-0518","doi":"https://doi.org/10.1634/theoncologist.2019-0518","is_oa":true,"landing_page_url":"https://doi.org/10.1634/theoncologist.2019-0518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2019-0518","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G26160426","display_name":"Predicting and profiling long-term survival after immune checkpoint inhibition","funder_award_id":"K23CA204726","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000083166","display_name":"Vanderbilt Clinical Oncology Research Career Development Award","funder_award_id":"K12CA090625","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2990670839.pdf","grobid_xml":"https://content.openalex.org/works/W2990670839.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1987334928","https://openalex.org/W2090604832","https://openalex.org/W2101327682","https://openalex.org/W2117692326","https://openalex.org/W2128123076","https://openalex.org/W2149639441","https://openalex.org/W2149696605","https://openalex.org/W2174557931","https://openalex.org/W2314203153","https://openalex.org/W2504029120","https://openalex.org/W2510322008","https://openalex.org/W2590837684","https://openalex.org/W2621266854","https://openalex.org/W2752276546","https://openalex.org/W2760246662","https://openalex.org/W2768592202","https://openalex.org/W2786396800","https://openalex.org/W2809965878","https://openalex.org/W2883867769","https://openalex.org/W2885288866"],"related_works":["https://openalex.org/W2752700185","https://openalex.org/W2947778893","https://openalex.org/W2905148438","https://openalex.org/W4391430347","https://openalex.org/W3213276801","https://openalex.org/W2026053174","https://openalex.org/W6901889441","https://openalex.org/W3030386566","https://openalex.org/W3097304584","https://openalex.org/W4394853148"],"abstract_inverted_index":{"Anti-programmed":[0],"cell":[1],"death":[2],"protein-1":[3],"(anti-PD-1)":[4],"therapy":[5,29,61],"has":[6],"greatly":[7],"improved":[8,120,191],"outcomes":[9,192],"of":[10,45,70,165,183],"patients":[11,55,71,98,125,139,194],"with":[12,27,56,59,99,107,155,158,190,195,198],"melanoma;":[13],"however,":[14],"many":[15],"fail":[16],"to":[17,208],"respond.":[18],"Although":[19],"preclinical":[20],"studies":[21],"suggest":[22],"a":[23,117],"potentially":[24],"synergistic":[25],"relationship":[26],"anti-PD-1":[28,60,199],"and":[30,50,84,102,202],"certain":[31],"concurrent":[32,184],"medications,":[33],"their":[34],"clinical":[35],"role":[36],"remains":[37],"unclear.":[38],"Here,":[39],"we":[40],"retrospectively":[41],"evaluated":[42],"the":[43,67],"use":[44,106,157,164,189],"nonsteroidal":[46],"anti-inflammatory":[47],"drugs":[48,52],"(NSAIDs)":[49],"other":[51,187],"in":[53,97,111,124,193],"330":[54],"melanoma":[57,196],"treated":[58,197],"from":[62],"four":[63],"academic":[64],"centers.":[65],"In":[66],"cohort,":[68],"37%":[69],"used":[72],"NSAIDs":[73,88,128,142],"including":[74],"aspirin":[75],"(acetylsalicylic":[76],"acid;":[77],"ASA;":[78],"47%),":[79],"cyclooxygenase":[80],"(COX)-2":[81],"inhibitors":[82],"(2%),":[83],"non-ASA/nonselective":[85],"COX":[86],"inhibitor":[87],"(59%).":[89],"The":[90],"objective":[91],"response":[92],"rates":[93],"(ORRs)":[94],"were":[95],"similar":[96],"NSAID":[100,104,156,185],"(43.4%)":[101],"no":[103,108,180],"(41.3%)":[105],"significant":[109],"difference":[110],"overall":[112],"suvival":[113],"(OS).":[114],"There":[115],"was":[116],"trend":[118],"toward":[119],"progression-free":[121],"survival":[122],"(PFS)":[123],"who":[126],"took":[127,141],"(median":[129],"PFS:":[130],"8.5":[131],"vs.":[132],"5.2":[133],"months;":[134],"p":[135],"=":[136],".054).":[137],"Most":[138],"(71.3%)":[140],"once":[143],"daily":[144],"or":[145,161,167,175,186],"as":[146],"needed.":[147],"Multivariate":[148],"analysis":[149,205],"did":[150,170],"not":[151,171],"reveal":[152],"an":[153],"association":[154,182],"ORR,":[159,173],"PFS,":[160,174],"OS.":[162,176],"Concurrent":[163],"metformin":[166],"beta":[168],"blockers":[169],"affect":[172],"Our":[177],"study":[178],"found":[179],"conclusive":[181],"medication":[188],"therapy.":[200],"Larger":[201],"more":[203],"systematic":[204],"is":[206],"required":[207],"confirm":[209],"these":[210],"findings.":[211]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-12-05T00:00:00"}